PROPRIOCIDAL APOPTOSIS OF MATURE T-LYMPHOCYTES OCCURS AT S-PHASE OF THE CELL-CYCLE

被引:249
作者
BOEHME, SA
LENARDO, MJ
机构
[1] NIAID, IMMUNOL LAB,9000 ROCKVILLE PIKE,BLDG 10, ROOM 11N311, BETHESDA, MD 20892 USA
[2] NCI, BIOL RESPONSE MODIFIERS PROGRAM, BETHESDA, MD 20892 USA
关键词
APOPTOSIS; CELL CYCLE; MATURE T-LYMPHOCYTES; PROPRIOCIDAL REGULATION;
D O I
10.1002/eji.1830230724
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We found that mature nontransformed CD4+ and CD8+ T lymphocytes could be made susceptible to T cell receptor(TcR)-mediated apoptosis by pretreatment with interleukin-4 (IL-4) or interleukin-2 (IL-2). The degree of susceptibility to death could be correlated with the level of cell cycling as measured by thymidine incorporation, cell doubling times, or the number of cells incorporating bromodeoxyuridine during S phase. However, using pharmacologic cell cycle blocking agents,we found that progression through the cell cycle was not required for cell death. Rather, we found that cells must be in a certain phase of the cell cycle to be susceptible to TcR-mediated death. Cells blocked in G1 phase were resistant to T cell receptor-induced apoptosis, whereas cells blocked in S phase were susceptible. These observations suggest that an important feature of growth lymphokines is their ability to drive T cells into portions of the cell cycle where they are sensitive to antigen receptor-induced apoptosis. Furthermore, these results provide additional evidence that the T cell growth lymphokines IL-2 and IL-4 may participate in the down-regulation of T cell responses by apoptosis - a pathway we have termed ''propriocidal regulation''.
引用
收藏
页码:1552 / 1560
页数:9
相关论文
共 59 条
[1]  
ADAMS RLP, 1981, BIOCH NUCLEIC ACIDS
[2]   CELL-GROWTH CYCLE BLOCK OF T-CELL HYBRIDOMAS UPON ACTIVATION WITH ANTIGEN [J].
ASHWELL, JD ;
CUNNINGHAM, RE ;
NOGUCHI, PD ;
HERNANDEZ, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (01) :173-194
[3]   CELL-DEATH AND CONTROL OF CELL-SURVIVAL IN THE OLIGODENDROCYTE LINEAGE [J].
BARRES, BA ;
HART, IK ;
COLES, HSR ;
BURNE, JF ;
VOYYODIC, JT ;
RICHARDSON, WD ;
RAFF, MC .
CELL, 1992, 70 (01) :31-46
[4]   ACTIVATION OF PROGRAMMED CELL-DEATH (APOPTOSIS) BY CISPLATIN, OTHER ANTICANCER DRUGS, TOXINS AND HYPERTHERMIA [J].
BARRY, MA ;
BEHNKE, CA ;
EASTMAN, A .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (10) :2353-2362
[5]  
BOEHME SA, 1993, IN PRESS LEUKEMIA
[6]  
COHEN JJ, 1991, ADV IMMUNOL, V50, P55
[7]  
COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.iy.10.040192.001411
[8]  
COLIGAN JE, 1992, CURRENT PROTOCOLS IM
[9]  
COTTER TG, 1990, ANTICANCER RES, V10, P1153
[10]  
DUKE RC, 1986, J IMMUNOL, V137, P1442